Page last updated: 2024-08-05 15:39:48

cathepsin L (EC 3.4.22.15) inhibitor

An EC 3.4.22.* (cysteine endopeptidase) inhibitor which interferes with the action of cathepsin L (EC 3.4.22.15).

ChEBI ID: 70821

Members (3)

MemberDefinitionClass
benzyloxycarbonylphenylalanylphenylalanine diazomethyl ketoneA diazo compound that is L-phenylalanyl-L-phenylalanine in which the amino group is protected by a (benzyloxy)carbonyl group and the carboxy group is substituted by a diazoacetyl group. It is a cathepsin L inhibitor.Z-Phe-Phe-CHN2
sid 26681509A carbohydrazide that is L-tryptophan in which the amino and carboxy groups are substituted by tert-butoxycarbonyl and 2-({[2-(2-ethylanilino)-2-oxoethyl]sulfanyl}carbonyl)hydrazinyl groups, respectively. It is a potent and reversible inhibitor of human cathepsin L (IC50 = 56 nM).SID 26681509
tln 4601diazepinomicin

Research

Studies (29)

TimeframeStudies, Drugs with This Role(%)All Drugs %
pre-19905 (17.24)18.7374
1990's5 (17.24)18.2507
2000's8 (27.59)29.6817
2010's8 (27.59)24.3611
2020's3 (10.34)2.80

Study Types

Publication TypeStudies, Drugs with this Role (%)All Drugs (%)
Trials1 (3.45%)5.53%
Reviews2 (6.90%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (89.66%)84.16%

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
Procathepsin LHomo sapiens (human)IC500.054033
procathepsin L isoform 1 preproproteinHomo sapiens (human)IC500.201411